The Natural Product (-)-epigallocatechin 3-gallate molecularly interacts with the Enzyme or Transporter CYP3A Gene Locus.     The Drug simvastatin directly negatively regulates activity of the Enzyme or Transporter CYP3A Gene Locus.     And the Drug simvastatin is causally causes or contributes to condition the Adverse Event myopathy.

Natural Product Ontology Identifier: http://napdi.org/napdi_srs_imports:camellia_sinensis
Natural Product or Constituent Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_4806
Process Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002436
Enzyme or Transporter Ontology Identifier: http://purl.obolibrary.org/obo/PR_1002
Process or Pathway Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002449
Drug Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_9150
Causal Relation Ontology Identifier: http://purl.obolibrary.org/obo/RO_0003302
Adverse Event Ontology Identifier: http://purl.obolibrary.org/obo/MONDO_0005336
